NCT01125566 · Interventional trial
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Overall registry status Completed
Phase 3
Conditions Breast Neoplasms
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory